WebIRVINE, Calif., Nov. 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients... WebApr 13, 2024 · IRVINE, Calif., April 13, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced today that it will release its first quarter 2024 financial results on Wednesday, …
Inari Medical to Announce First Quarter 2024 Financial Results
WebMar 17, 2024 · Inari Medical Announces First Patient Enrolled in the DEFIANCE Trial, Randomized Controlled Trial Evaluating Clinical Outcomes of the ClotTriever® System in … WebMar 6, 2024 · IRVINE, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company with a mission to treat and transform the lives of patients... photochromic polarized glasses for women
Inari Medical Reports Fourth Quarter and Full Year 2024 Financial ...
WebMay 7, 2024 · IRVINE, CALIFORNIA – July 2, 2024 — Inari Medical, Inc. announced today that the company has appointed Thomas M. Tu, M.D. as Chief Medical Officer. Dr. Tu is a … Web1 day ago · In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent … WebNov 2, 2024 · IRVINE, Calif., Nov. 02, 2024 (GLOBE NEWSWIRE) — Inari Medical, Inc. ( NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its third quarter ended September 30, 2024. photochromic safety glasses ansi